Health · 8 September 2026
Experimental cancer drug CADD522 treats osteoporosis and weight gain in mice
Unsplash / FÍA YANG
An experimental cancer drug called CADD522 has demonstrated potential for decreasing bone mass and adipose tissue in mice, replicating post-menopausal changes. The University of East Anglia-led study found the compound strengthened bones and helped animals stay leaner despite eating the same amount. Researchers hope these benefits will translate to humans, potentially reducing fracture rates for millions of women over 50.
Reported by femtechworld.co.uk · How we write briefs